OHRS News & Alerts
05/10/13IMPORTANT: Research Community ListServ Communications
04/16/13Quarterly Forms Update - Spring 2013
3/11/13Off-Cycle Winter/Spring Forms Update
2/5/13Quality Improvement Determination Form
1/11/13Quarterly Forms Update - Winter 2013
11/15/12Expanded Consent Language Database
11/9/12OHRS Submit Downtime - OncPro will NOT be affected
10/9/12Quarterly Forms Update - Fall 2012
9/7/12OHRS Submit Downtime Due to Database Maintenance
8/10/12OHRS Submit Downtime Due to LiveLink Upgrade Preparations
7/27/12OHRS Submit Downtime Due to LiveLink Upgrade Preparations
7/26/12Clarifications and Minor Form Corrections
7/13/12OHRS Submit Downtime
7/9/12OHRS Quarterly Forms Update - Summer 2012
6/20/12Update on OncPro & OHRS Submit and Important Information Regarding OncPro Downtime
4/13/12Spring Forms and Document Update4/2/12OncPro & 90 Day Reminder Notice Changes
2/27/12Office for Human Research Studies (OHRS) Off Cycle FORMS UPDATE
1/6/12Office for Human Research Studies (OHRS) QUARTERLY FORMS UPDATE Winter 2012
10/17/11The Advance Notice of Proposed Rule Making (ANPRM)
10/12/11OHRS Forms and Submission Update
9/26/11Pre-Review Process for Adult Clinical Trials
9/1/11OHRS Forms and Submission Update
8/26/11Information Relating to the ANPRM Proposal to Revise the Human Subject Protection Regulations
7/1/11OHRS Forms & Templates Updated
5/31/11OHRS Forms Updated
5/6/11Changes to OHRS Forms and Guidance
4/4/11Upcoming Conference
3/4/11Consent Form Reminders
2/16/11OHRS Update Address
1/31/11Open Letter to Sponsors Change
1/27/11RTU Form, Add Site Checklist & CTSU Form Letter Change
1/20/11Reminder Regarding Submissions of PDF documents to OHRS & Receipt of Courtesy Notices of Review Dates
11/3/10Reminder to Principal Investigators of Responsibility to Review all IND/IDE Safety Reports
11/3/10Continuing Review Form Changes
10/19/10OHRS News Alert: Potential Safety Issue with Carboplatin Dosing and Serum Creatinine Measurement
8/13/10Biomedical and Social/Behavioral Research Consent Form Changes
8/2/10Reminder Regarding Policies for Reporting Non-Compliance in accordance with the Deviation/Violation/Exception Reporting Policy
6/21/10OHRS Update On Guidance For Completing Protocol Front Sheets
6/18/10OHRS Update On Research Staff Identified On Front Sheets
6/7/10OHRS Updates - Continuing Review Form Revised & New Information Sheet Added Regarding Drug Shortage Procedures
5/14/10New Guidance Pertaining to Participating Satellite Institutions, Informed Consent Template,& New Project Application Forms
4/22/10OHRS News: Forms & CR Submission Time Frame Changes
4/14/10Disease Program Leader List Updated
1/26/10OHRS News Alert: FDA Notice Regarding Velcade
12/4/09Revised Policy, Forms & Guidance Documents
11/6/09Change in CTSU IRB Certification Letter for DF/HCC
10/23/09New OHRS Office Hours Program
10/22/09Change in Letter to Sponsors Document
8/14/09Updated Information Letters to Sponsors
8/14/09Training for Newly Enhanced OHRS Submit
7/1/09OHRS Forms & Information Sheet Changes
4/30/09Updated Program Leader List for Endorsement Forms
4/14/09OHRS Forms & Website Updates
4/2/09Notice Regarding IRB Review of Stimulus Fund-Related Protocols
2/23/09New OHRS Information Sheet & Related Changes
1/28/09Updated Policies & Procedures for the Endorsement of New Research Protocols
1/28/09Revised Forms Posted on OHRS Website
1/20/09OHRS Submit Submissions
12/31/08Notice of Revised OHRS Forms Posted for Use
12/23/08Inclement Weather and Holiday Scheduling
12/18/08Revisions to Letter to Sponsors Concerning DFCI IRB Policy on Re-Consenting Subjects
12/3/08Overview of the Operations of the DFCI Institutional Review Boards
12/2/08New Resources for Risk Language
11/3/08New & Revised OHRS Information Sheets Posted
9/19/08New Forms Posted on OHRS Website
8/12/08New Forms Posted to the OPRS Website
8/4/08New Form - Request to Continue Research Intervention
7/23/08Guidance Document & Revised Front Sheet Template
6/19/08New Alert Page Template and Guidance
4/4/08Guidance Document: Consent for Continued Participation in a Research Study By a Young Adult Who Has Reached Age 18
4/4/08OPRS Alert - Changes in Dose Preparation/Administration
4/1/08New Procedures for Communicating Changes in Study-wide and DF/HCC Accrual Figures to OPRS and the IRB
1/11/08Revised Application for Continuing Review Form
1/2/08National Shortage of Radiopharmaceuticals and Protocols Deviations; Changes to OPRS Forms
10/4/07Priority List Form Addition & Changes to Other Forms Including New Clinical Trials Application Form
7/26/07OPRS Submit Enhancement and Amendment Submission Clarification
7/12/07The Major Deviation/Violation/Exception Form Updated
7/12/07OPRS Submit Enhancement for Dose Escalation Cohort Changes
4/30/07Revised Forms and New Information Sheets Available
4/12/07Overview of Policy Change
11/28/06New OPRS Information Sheet – How to Contact the FDA
11/6/06Various OPRS Update Highlights (compliance updates and more)
9/11/06 ONCPRO Enhancement for New User Sign Up
8/24/06Directed To Principal Investigators And Study Staff Of Protocols That Involve Tissue Collection
8/11/2006The following news update from OPRS highlights CTEP CTCAE v3.0 Adverse Event Lay Terms
6/20/2006The following news update from OPRS highlights new templates, letters and OPRS staff members
4/27/2006 The following news update from OPRS highlights various issues relating to protocol submissions and post-approval protocol events
4/13/06OPRS Submit Changes with Violations, Deviations and Exceptions
2/13/06DFCI Policy on Reporting Deviations/ Violations/ Exceptions to OPRS
11/22/05OPRS Alert - FDA Guidance for Estimating the Maximum Safe Starting Dose